Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 3, 2009, Pages 463-469

  Pintor, Luis ^a   Torres, Xavier ^a   Navarro, Victor ^a   Martinez de Osaba, Ma Jesús ^a   Matrai, Silvia ^a   Gastó, Cristobal ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Corticotropin releasing factor; Cortisol; Depression; Prediction; Relapse

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; HYDROCORTISONE; IMIPRAMINE; PHENELZINE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOTROPIN RELEASING FACTOR STIMULATION TEST; FEMALE; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MALE; MELANCHOLIA; PREDICTION; PROVOCATION TEST; RECURRENT DISEASE; RELAPSE; REMISSION; SENSITIVITY AND SPECIFICITY; STRESS; SUICIDE ATTEMPT;

ADRENOCORTICOTROPIC HORMONE; ADULT; CHI-SQUARE DISTRIBUTION; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYDROCORTISONE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY; RECURRENCE; RETROSPECTIVE STUDIES; ROC CURVE; TIME FACTORS;

EID: 62849110780     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.01.008     Document Type: Article

References (41)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Pres, Washington, DC
2. Amsterdam J.D., Maislin G., Winokur A., Berwish N., Kling M., and Gold P. The oCRH stimulation test before and after clinical recovery from depression. J Affect Disord 14 (1988) 213-222
3. 1-24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry 140 (1983) 907-909
4. Appelhof B.C., Huyser J., Vermeij M., Brouwer J.P., Van Dick R., Fliers E., et al. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol Psychiatry 59 (2006) 696-701
5. Aubry J.M., Gervasoni N., Osiek C.h., Perret G., Rossier M.F., Bertschy G., et al. The DEX/CRH neuroendocrine test and prediction of depressive relapse in remitted depressed outpatients. J Psychiatr Res 41 (2007) 290-294
6. Bech P., and Rafaelsen O.J. The use of rating scales exemplified by a comparison of the Hamilton and the Bech Rafaelsen Melancholia Scale. Act Psychiatr Scand 62 Suppl 185 (1980) 128-132
7. Carney M.W.P., and Sheffield B.F. Depression and the Newcastle scales: their relationship to Hamilton's scale. Br J Psychiatry 121 (1972) 35-40
8. Catalán R., Gallart J.M., Castellanos J.M., and Galard R. Plasma corticotropin releasing factor in depressive disorders. Biol Psychiatry 44 (1998) 15-20
9. Chrousos G.P., Calabrese J.R., Avgerinos P., Kling M.A., Rubinow D., Oldfield E.H., et al. Corticotropin releasing factor: basis studies and clinical applications. Prog Neuro-Psychopharmacol Biol Psychiatry 9 (1988) 349-359
10. Demidovich B.P., and Maron I.A. Cálculo numérico fundamental (Segunda edición) (1985), Paraninfo, Madrid
11. Endicott, J., Andreasen, N., Spitzer, R.L., (1978). Family History-Research Diagnostic Criteria, 3rd Edition. New York, Biometrics Research, New York State Psychiatric Institute. (Traducción al castellano: MS Humbert, J Buigues, 1986).
12. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders- clinician version (SCID-CV) (1997), American Psychiatry Association Press, Washington DC (Spanish version, Masson SA, 1999)
13. Frank E., Prien R.F., Jarret R.B., Keller M.B., Kupfer D.J., Lavori P.W., et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48 (1991) 851-855
14. Gartside S.E., Leitch M.M., and Young A.H. Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression. Neuropsychopharmacology 28 (2003) 1572-1578
15. Gold P.W., Loriaux D.L., Roy A., Kling M.A., Calabrese J.R., Kellner C.H., et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 314 (1986) 1329-1335
16. Greist J.H., and Jefferson J.W. Depression and its treatment (1992), American Psychiatric Press, Washington, DC Revised Edition
17. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
19. Heuser I., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., et al. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 153 (1996) 93-99
20. Holsboer F., Müller O.A., Doerr H.G., Sipell W.G., Stalla G.K., Gerken A., et al. ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression. Psychoneuroendocrinology 9 (1984) 147-160
21. Holsboer-Trachsler E., Hemmeter U., Hatzinger M., Seifritz E., Gerhard U., Hobi V., et al. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment- neurobiological and psychometric assessment of course. J Psychiatr Res 28 (1994) 381-399
22. Hosmer D.W., and Lemeshow S. Applied logistic regression (1989), Willey, New York
23. Jennings D.E. Judging inference adequacy in logistic regression. J Am Stat Assoc 81 (1986) 471-476
24. Kathol R.G. Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding. J Affect Disord 8 (1985) 137-145
25. Kendler K.S., Kessler R.C., Walters E.E., MacLean C., Neale M.C., Heath A.C., et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 152 (1995) 833-842
26. Kessing L.V., Andersen P.K., and Mortensen P.B. Predictors of recurrence in affective disorder: a case register study. J Affect Disord 49 (1998) 101-108
27. Maes M., Claes M., Vandewoude M., Schotte C., Martin M., Blockx P., et al. ACTH, beta-endorphin and cortisol responses to oCRH in melancholic patients. Psychol Med 22 (1992) 317-329
28. Modell S., Lauer C.J., Schreiber W., Huber J., Krieg J.C., and Holsboer F. Hormonal response pattern in the combined DEX-CRF test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18 (1998) 253-262
29. Nemeroff C.B. The corticotropin releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1 (1996) 336-342
30. Nemeroff C.B., and Evans D.L. Correlation between the dexamethasone suppression test in depressed patients and clinical response. Am J Psychiatry 141 (1984) 247-249
31. O'Toole S.M., Sekula L.K., and Rubin R.T. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression. Biol Psychiatry 42 (1997) 85-89
32. Owashi T., Otsubo T., Oshima A., Nakagome K., Higuchi T., and Kamijima K. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression. Psychoneuroendocrinology 33 (2008) 152-161
33. Paykel E.S., Cooper Z., Ramana R., and Hayhurst H. Life events, social support and marital relationships in the outcome of severe depression. Psychol Med 26 (1996) 121-133
34. Pintor L., Torres X., Navarro V., Martinez de Osaba M.J., Matrai S., and Gastó C. Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: a comparative study. Prog NeuroPsychopharmacol Biol Psychiatry 31 (2007) 1027-1033
35. Pintor L., Torres X., Navarro V., Matrai S., and Gastó C. Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow-up?. J Affect Disord 82 (2004) 291-296
36. Rybakowski J.K., and Twardowska K. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 33 (1999) 363-370
37. Schmider J., Lammers C.H., Gotthardt U., Dettling M., Holsboer F., and Heuser I.J. Combined dexamethasone/corticotropin releasing hormone test in acute and remitted manic patients, in acute depression and in normal controls: I. Biol Psychiatry 15 (1995) 797-802
38. Van Den Eede F., Van den Bossche B., Hulstijn W., Sabbe B.G.C., Cosyns P., and Claes S.J. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder. J Affect Disord 93 (2006) 259-263
39. Vieta E., Gastó C., Martínez de Osaba M.J., Nieto E., Cantó T.J., and Otero A. Prediction of depressive relapse in remitted bipolar patients using corticotropin-releasing hormone challenge test. Act Psychiatr Scand 95 (1997) 205-211
40. Zimmerman M., Posternak M.A., and Chelminski I. Defining remission on the Montgomery-Asberg depression rating scale. J Clin Psychiatry 65 (2004) 163-168
41. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., and Ising M. Cortisol response in the combined dexamethasone-CRH test as predictor of relapse in patients with remitted depression: a prospective study. J Psychiatr Res 35 (2001) 83-94